GlassScriptPhysician profile
Anika Ackerman
NPI 1326307877
$24,694.33
in general payments reported to CMS, 2019-2025
45 companies · $21K in 2025
The $21K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $155 · 2021: $68.46 · 2022: $619 · 2023: $1,242 · 2024: $1,148 · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Food and Beverage: $3,545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,100.00 |
| Food and Beverage | $3,545.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $20,078.05 | 2019-2025 | Erleada |
| Medtronic, INC. | $513.00 | 2023-2025 | Interstim, Kyphon Express II Kyphopak Tray, Solitaire X |
| Calyxo, INC. | $328.53 | 2024-2025 | Cvac Aspiration System |
| Astellas Pharma US INC | $281.06 | 2021-2024 | Veozah, Myrbetriq |
| Allergan, INC. | $257.89 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $248.36 | 2023-2025 | Gemtesa |
| Tolmar, INC. | $213.51 | 2023-2025 | Jatenzo, Eligard |
| Coloplast Corp | $198.49 | 2023-2025 | Speedicath |
| Abbvie INC. | $180.73 | 2022-2025 | Botox, Lupron Depot |
| Immunitybio, INC. | $173.67 | 2024-2025 | |
| 180 Medical, INC. | $166.91 | 2019-2025 | |
| Caldera Medical, INC | $160.42 | 2023 | Desara |
| Ferring Pharmaceuticals INC. | $158.28 | 2024 | Adstiladrin |
| C. R. Bard, INC. & Subsidiaries | $145.89 | 2023-2025 | Purewick Female External Catheter, Bard Urinary Drainage Bag |
| Olympus America INC. | $134.84 | 2022-2025 | Soltive, Itind System |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $120.16 | 2021-2024 | Xyosted |
| Axonics, INC. | $116.69 | 2020-2024 | Bulkamid, Axonics |
| Vectivbio Ag | $100.00 | 2023 | |
| Edap Technomed INC | $100.00 | 2023 | |
| Neotract INC. | $97.89 | 2020 | |
| Teleflex LLC | $80.48 | 2023-2025 | Urolift, Barrigel |
| Endo Pharmaceuticals INC. | $77.83 | 2022-2023 | Aveed, Xiaflex |
| Kowa Pharmaceuticals America, INC. | $72.37 | 2022-2023 | Seglentis |
| Endo USA, INC. | $67.40 | 2024-2025 | Xiaflex, Aveed |
| Bayer Healthcare Pharmaceuticals INC. | $49.15 | 2019-2023 | |
| Photocure INC | $48.11 | 2019-2023 | Cysview |
| Ethicon US, LLC | $48.02 | 2019-2025 | Echelon Flex |
| Agiliti Surgical, INC. | $46.86 | 2023 | Trinity, Sonablate |
| Acerus Pharmaceuticals Corporation | $45.00 | 2022 | |
| Boston Scientific Corporation | $43.09 | 2023-2025 | General - Female Sui |
| Bluewind Medical | $39.76 | 2024-2025 | |
| Bioprotect Medical, INC. | $36.63 | 2024 | Bioprotect Balloon Implant System |
| Corcept Therapeutics | $34.50 | 2019-2024 | Korlym |
| Amag Pharmaceuticals, INC. | $30.71 | 2019 | |
| Pfizer INC. | $30.54 | 2019-2024 | |
| Procept Biorobotics Corporation | $22.17 | 2023 | Aquabeam Robotic System |
| Progenics Pharmaceuticals, INC. | $21.11 | 2025 | |
| Civco Medical Instruments | $19.20 | 2023 | |
| Myriad Genetic Laboratories, INC. | $18.00 | 2022 | |
| Urogen Pharma, INC. | $16.58 | 2023 | Jelmyto |
| Merck Sharp & Dohme LLC | $14.99 | 2019 | |
| Dendreon Pharmaceuticals LLC | $14.96 | 2019 | |
| Zyla Life Sciences, INC. | $14.94 | 2019 | |
| Urovant Sciences INC | $14.17 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $13.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anika Ackerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.